Amoul® is dedicated to provide comprehensive emergency care total solutions to healthcare workers and patients worldwide. Our highly qualified R&D team is always striving to innovate insightful critical care devices to support life by following best of quality standards. Amoul® owns wide range of Patents, certifications, and honors from around the globe.

On 9th April, 2020 the USA Food and Drug Administration (FDA)  approved Amoul® Ventilators, 6000S, T5 and T7 under Emergency Use Authorization (EUA). Its great honor for Amoul® and its partners worldwide.